Antiproliferative effect of soybean isoflavone on Bcap-37 cells and its relation with transforming growth factor β
	    		
		   		
	    	
    	
    	
   		
        
        	
        		- VernacularTitle:大豆异黄酮抑制Bcap-37细胞增殖与TGF-β关系的研究
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Zhenzhou YANG
			        		
			        		;
		        		
		        		
		        		
			        		Mantian MI
			        		
			        		;
		        		
		        		
		        		
			        		Jundong ZHU
			        		
			        		;
		        		
		        		
		        		
			        		Qianyong ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Jiguang XIONG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
            
            
            	- From:Journal of Third Military Medical University
	            		
	            		 2001;23(4):434-436
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the expression of TGF-β and TGF-β receptor in human breast cancer cell Bcap-37 inhibited by soybean isoflavones. Methods mRNA and protein of TGF-β1、TGF-βRⅠ in Bcap-37 cells were examined with reverse transcription ploymerase chain reaction(RT-PCR) and immunohistochemistry after cells were treated with daidein or genistein for 1-4 d.The expression of TGF-β1 and TGF-β2 was determined with TGF-β resistance test. Results The TGF-β1, TGF-β2 and TGF-β recepor increased in Bcap-37 cells at a concentration of 3×10-5 mol/L of genistein. No changes was found when treated with daidzein. Conclusion Genistein may inhibit the proliferation of Bcap-37 cells and accompany with increasing expression of TGF-β1, TGF-β2 and TGF-β receptor.